CIK 0001094038 · Non-accelerated filer<br>Smaller reporting company
Marker Therapeutics, Inc.
Sign in to watch- Ticker
- MRKR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880277072
- Phone
- (713) 400-6400
- Business address
- 2450 HOLCOMBE BLVD, TMC PARTNERS OFFICE 1.311, HOUSTON, TX, 77021
- Former names
- TAPIMMUNE INC., TAPIMMUNE INC, GENEMAX CORP, EDUVERSE COM
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-Q Report Quarterly Report
- NT 10-Q Other NT 10-Q
- UPLOAD Other SEC-generated Letter
- 10KSB/A Other 10KSB/A
- 10-Q Report Quarterly Report
- REGDEX Other REGDEX
- NT 10-Q Other NT 10-Q
- 4 Insider Changes in Ownership
- UPLOAD Other SEC-generated Letter
- 4 Insider Changes in Ownership
- 8-K Event Other events
- 10-Q Report Quarterly Report
- NT 10-Q Other NT 10-Q
- 10KSB Other 10KSB
- NT 10-K Other NT 10-K
- 8-K Event Other events
- 8-K Event Acquisition or sale completed · Other events
- 10QSB Other 10QSB
Page 36 of 46 · 904 filings